A Johns Hopkins study finds teens with cannabis use disorder face higher risks of schizophrenia, depression, and anxiety than peers using other substances.

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Could hyperbaric oxygen treat PTSD, depression, and anxiety? New evidence suggests that this treatment may rewire the ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Nonprofit Project Blackbird uses film and discussion to help students open up about mental health, eating disorders and ...

The FAMILY consortium, an EU-funded study, aims to understand the intergenerational transmission of mental illness risk ...

A massive global genetics study is reshaping how we understand mental illness—and why diagnoses so often pile up. By analyzing genetic data from more than six million people, researchers uncovered ...

EATONTOWN, NJ - March 20, 2026 - PRESSADVANTAGE - Advanced Health & Education, a Joint Commission-accredited mental ...

Genetic research is rapidly overturning the idea that each psychiatric diagnosis is a separate island. Large DNA studies now suggest that many mental health conditions are different expressions of a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. More than half of adult patients with IBD had at least ...